197 related articles for article (PubMed ID: 19957378)
1. Chronic administration of valproic acid inhibits activation of mouse hepatic stellate cells in vitro and in vivo.
Mannaerts I; Nuytten NR; Rogiers V; Vanderkerken K; van Grunsven LA; Geerts A
Hepatology; 2010 Feb; 51(2):603-14. PubMed ID: 19957378
[TBL] [Abstract][Full Text] [Related]
2. Neuroendocrine transdifferentiation induced by VPA is mediated by PPARgamma activation and confers resistance to antiblastic therapy in prostate carcinoma.
Angelucci A; Muzi P; Cristiano L; Millimaggi D; Cimini A; Dolo V; Miano R; Vicentini C; Cerù MP; Bologna M
Prostate; 2008 May; 68(6):588-98. PubMed ID: 18288684
[TBL] [Abstract][Full Text] [Related]
3. Sodium valproate blocks the transforming growth factor (TGF)-β1 autocrine loop and attenuates the TGF-β1-induced collagen synthesis in a human hepatic stellate cell line.
Watanabe T; Tajima H; Hironori H; Nakagawara H; Ohnishi I; Takamura H; Ninomiya I; Kitagawa H; Fushida S; Tani T; Fujimura T; Ota T; Wakayama T; Iseki S; Harada S
Int J Mol Med; 2011 Dec; 28(6):919-25. PubMed ID: 21822535
[TBL] [Abstract][Full Text] [Related]
4. Crosstalk between Epigenetic Modulations in Valproic Acid Deactivated Hepatic Stellate Cells: An Integrated Protein and miRNA Profiling Study.
Lu P; Yan M; He L; Li J; Ji Y; Ji J
Int J Biol Sci; 2019; 15(1):93-104. PubMed ID: 30662350
[TBL] [Abstract][Full Text] [Related]
5. Valproate ameliorates thioacetamide-induced fibrosis by hepatic stellate cell inactivation.
Aher JS; Khan S; Jain S; Tikoo K; Jena G
Hum Exp Toxicol; 2015 Jan; 34(1):44-55. PubMed ID: 24812151
[TBL] [Abstract][Full Text] [Related]
6. Chronic administration of valproic acid inhibits PC3 cell growth by suppressing tumor angiogenesis in vivo.
Gao D; Xia Q; Lv J; Zhang H
Int J Urol; 2007 Sep; 14(9):838-45. PubMed ID: 17760752
[TBL] [Abstract][Full Text] [Related]
7. Multiple Molecular pathways explain the anti-proliferative effect of valproic acid on prostate cancer cells in vitro and in vivo.
Shabbeer S; Kortenhorst MS; Kachhap S; Galloway N; Rodriguez R; Carducci MA
Prostate; 2007 Jul; 67(10):1099-110. PubMed ID: 17477369
[TBL] [Abstract][Full Text] [Related]
8. A histone deacetylase inhibitor, trichostatin A, suppresses myofibroblastic differentiation of rat hepatic stellate cells in primary culture.
Niki T; Rombouts K; De Bleser P; De Smet K; Rogiers V; Schuppan D; Yoshida M; Gabbiani G; Geerts A
Hepatology; 1999 Mar; 29(3):858-67. PubMed ID: 10051490
[TBL] [Abstract][Full Text] [Related]
9. Chronic administration of valproic acid inhibits prostate cancer cell growth in vitro and in vivo.
Xia Q; Sung J; Chowdhury W; Chen CL; Höti N; Shabbeer S; Carducci M; Rodriguez R
Cancer Res; 2006 Jul; 66(14):7237-44. PubMed ID: 16849572
[TBL] [Abstract][Full Text] [Related]
10. C/EBP-α ameliorates CCl(4)-induced liver fibrosis in mice through promoting apoptosis of hepatic stellate cells with little apoptotic effect on hepatocytes in vitro and in vivo.
Tao LL; Cheng YY; Ding D; Mei S; Xu JW; Yu J; Ou-Yang Q; Deng L; Chen Q; Li QQ; Xu ZD; Liu XP
Apoptosis; 2012 May; 17(5):492-502. PubMed ID: 22307857
[TBL] [Abstract][Full Text] [Related]
11. In vivo anti-myeloma activity and modulation of gene expression profile induced by valproic acid, a histone deacetylase inhibitor.
Neri P; Tagliaferri P; Di Martino MT; Calimeri T; Amodio N; Bulotta A; Ventura M; Eramo PO; Viscomi C; Arbitrio M; Rossi M; Caraglia M; Munshi NC; Anderson KC; Tassone P
Br J Haematol; 2008 Nov; 143(4):520-31. PubMed ID: 18986388
[TBL] [Abstract][Full Text] [Related]
12. Increased replication of human cytomegalovirus in retinal pigment epithelial cells by valproic acid depends on histone deacetylase inhibition.
Michaelis M; Suhan T; Reinisch A; Reisenauer A; Fleckenstein C; Eikel D; Gümbel H; Doerr HW; Nau H; Cinatl J
Invest Ophthalmol Vis Sci; 2005 Sep; 46(9):3451-7. PubMed ID: 16123451
[TBL] [Abstract][Full Text] [Related]
13. Valproic acid inhibits human hepatocellular cancer cells growth in vitro and in vivo.
Machado MC; Bellodi-Privato M; Kubrusly MS; Molan NA; Tharcisio T; de Oliveira ER; D'Albuquerque LA
J Exp Ther Oncol; 2011; 9(2):85-92. PubMed ID: 21699015
[TBL] [Abstract][Full Text] [Related]
14. Hepatoprotection and lethality rescue by histone deacetylase inhibitor valproic acid in fatal hemorrhagic shock.
Gonzales ER; Chen H; Munuve RM; Mehrani T; Nadel A; Koustova E
J Trauma; 2008 Sep; 65(3):554-65. PubMed ID: 18784568
[TBL] [Abstract][Full Text] [Related]
15. Additive effects of histone deacetylase inhibitors and amphetamine on histone H4 acetylation, cAMP responsive element binding protein phosphorylation and DeltaFosB expression in the striatum and locomotor sensitization in mice.
Shen HY; Kalda A; Yu L; Ferrara J; Zhu J; Chen JF
Neuroscience; 2008 Dec; 157(3):644-55. PubMed ID: 18848971
[TBL] [Abstract][Full Text] [Related]
16. Valproic acid improves outcome after rodent spinal cord injury: potential roles of histone deacetylase inhibition.
Lv L; Sun Y; Han X; Xu CC; Tang YP; Dong Q
Brain Res; 2011 Jun; 1396():60-8. PubMed ID: 21439269
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D inhibits proliferation and profibrotic marker expression in hepatic stellate cells and decreases thioacetamide-induced liver fibrosis in rats.
Abramovitch S; Dahan-Bachar L; Sharvit E; Weisman Y; Ben Tov A; Brazowski E; Reif S
Gut; 2011 Dec; 60(12):1728-37. PubMed ID: 21816960
[TBL] [Abstract][Full Text] [Related]
18. Histone deacetylase inhibitor valproic acid inhibits proliferation and induces apoptosis in KM3 cells via downregulating VEGF receptor.
Dong XF; Song Q; Li LZ; Zhao CL; Wang LQ
Neuro Endocrinol Lett; 2007 Dec; 28(6):775-80. PubMed ID: 18063935
[TBL] [Abstract][Full Text] [Related]
19. Development of hepatic fibrosis occurs normally in AMPK-deficient mice.
da Silva Morais A; Abarca-Quinones J; Guigas B; Viollet B; Stärkel P; Horsmans Y; Leclercq IA
Clin Sci (Lond); 2009 Dec; 118(6):411-20. PubMed ID: 19852755
[TBL] [Abstract][Full Text] [Related]
20. Novel targets for valproic acid: up-regulation of melatonin receptors and neurotrophic factors in C6 glioma cells.
Castro LM; Gallant M; Niles LP
J Neurochem; 2005 Dec; 95(5):1227-36. PubMed ID: 16313512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
